Pulsating electromagnetic field therapy for diabetic foot ulcers
Official title: Evaluating the Efficacy of Pulsating Electromagnetic Field (PEMF) Therapy for Diabetic Foot Ulcers Using the CRAD ULCER X-01 Device: A Randomised Parallel-Group Pilot Study
Run by National Defence University of Malaysia · NCT07465640 · Data updated 2026-11-12
This trial tests whether a PEMF device called CRAD ULCER X-01 helps heal chronic diabetic foot ulcers when added to standard wound care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | National Defence University of Malaysia Academic / other |
| Locations | 1 site (Kuala Lumpur) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | September 1, 2027 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07465640 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with diabetes and a chronic, non-healing diabetic foot ulcer (Grade I-III, Stage A UT Classification) who consent to participate.
✕Probably not a fit
Patients with metal implants, pacemakers, malignancies, kidney disease, or other conditions increasing risk may not benefit and could be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the safety and potential efficacy of pulsating electromagnetic field therapy (PEMF) using the CRAD ULCER X-01 device in adults with chronic diabetic foot ulcers. Thirty-two participants with non-healing DFUs are recruited and assigned to a treatment or control group, with all receiving daily wound dressing and standard care; the treatment group uses PEMF for one hour daily. The study aims to see if PEMF can accelerate wound healing, reduce inflammation, and improve outcomes compared with standard care alone. Details on device parameters and full protocol are limited in the provided materials. The trial is conducted at Tuanku Mizan Armed Forces Hospital in Kuala Lumpur, led by the National Defence University of Malaysia.
Why it matters
Potential benefit: If successful, the PEMF treatment could speed up healing of chronic DFUs and reduce complications.
How similar studies have gone: Previous research has suggested PEMF may accelerate wound healing, but results in DFUs are variable and this study explores a specific device and protocol.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of written consent by subjects. * Subject of either sex. * At least 18 years of age. * Known diabetes mellitus. * Diagnosed with chronic DFU Grade I-III and Stage A according to the University of Texas Classification as recommended in the Malaysian Clinical Practice Guidelines for the Management of Diabetic Foot (2nd Edition). Exclusion Criteria: * Inability or unwillingness to provide written consent. * Inability or unwillingness to comply with the requirements of the protocol as determined by the investigator. * Other medical conditions which, in the investigator's judgement, may be associated with increased risk to the subject or may interfere with study assessments or outcomes. * Participation in another clinical trial and/or recipient of investigational therapy within 4 weeks prior to screening visit. * Patients who have metal implants in any part of the body. * Patients with a pacemaker. * History of malignancies. * Presence of chronic kidney disease co-morbidity. * Presence of severe peripheral artery disease, assessed when the ankle-brachial index (ABI) is \<0.40.
Where it's running
-
Tuanku Mizan Armed Forces Hospital
Kuala Lumpur, Malaysia Recruiting
Study contacts
- Study coordinator: Khairul Anwar Zarkasi, MBBS, MMedSc., PhD
- Email: khairul.anwar@upnm.edu.my
- Phone: +60178870689
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BIOxHEAL plus standard care for nonhealing diabetic foot ulcers
A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
L-Carnitine as an add-on for healing diabetic foot ulcers
This study tests whether taking L-Carnitine helps wound healing in adults with diabetic foot ulcers, alongside standard diabetes and wound care.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Pulsed electromagnetic field therapy for sensory changes in diabetic foot ulcers
This study tests whether low-frequency pulsed electromagnetic field therapy, with ankle range of motion, can improve protective sensation in people with type 2 diabetes and a Wagner grade 1 diabetic foot ulcer.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.